GENE ONLINE|News &
Opinion
Blog

CRISPR-CAS9
Groundbreaking CRISPR/Cas9-based Genome Editing Therapy Secured the Second FDA Approval
2024-01-18
GeneOnline’s Pick: Top 10 Global Biotech News Stories in 2023
2023-12-27
FDA Approves A CRISPR-Based Therapy for Sickle Cell Disease
2023-12-12
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
Treating Common Heart Disease with CRISPR-Cas9 Gene Editing
2022-12-27
Researchers Engineer “Mini” CRISPR-Cas System That Could Act as ‘Swiss Army Knife’ for Mammalian Genome Editing
2021-09-07
Emerging Gene Editing Technologies and Applications
2021-05-19
The Game Changer: New CRISPR Tool Can Turn On/Off Genes
2021-05-03
CRISPR Gene Editing Could Lead to Possible Detrimental Chromosomal Rearrangement
2021-04-25
Vertex to Reap Majority Profits from Gene Editing Deal with CRISPR Therapeutics
2021-04-21
Tracing Tumor Evolution and Metastasis Using a Molecular Flight Recorder
2021-04-13
A New Multiplex CRISPR Method in Plants Can Generate High-Order Mutants in One Shot
2021-04-04
10 Top Gene Therapy Companies in 2021
2021-03-26
Overview of the Gene Therapy Revolution: Hopeful Beginnings, Tribulations, and Resurgence
2021-03-23
BIOCEO21 Highlights: Novel CRISPR Delivery Method Puts the Spotlight on this Early Stage Biotech
2021-02-18
1 2 3
LATEST
Why NVIDIA’s CEO Huang Said AI Fostering Life Science:Highlighting GPU’s Applications in Biotech
2024-02-23
Revolutionary AI-Powered Respiratory Monitor Maker Gets Financial Boost with Latest Funding
2024-02-21
Researchers Predict Drug Interactions with Machine Learning to Enhance Patient Safety
2024-02-21
USC-Led Study Reveals Benefits of Fasting-Mimicking Diet in Reducing Disease Risk and Slowing Aging
2024-02-21
Astonishing brain tumour research wins the BIAL Award in Biomedicine 2023 worth 300,000 Euro
2024-02-21
Targeted Cancer Therapy Breakthrough: Degrader-Antibody Conjugates (DACs) Advance to Clinical Trials
2024-02-19
Degrader-Antibody Conjugates (DACs): Targeted Degradation for Therapeutics
2024-02-19
EVENT
Scroll to Top